Industry stocks

Biotechnology Stocks on NASDAQ

Compare NASDAQ-listed Biotechnology stocks by fair value, valuation, financial quality, profitability, risk, and market outlook.

INmune Bio Inc (INMB)
Fair Value-1.0% Downside Fair Analyst268.4% Upside Market Cap50.778 M P/E-1.2x Yield0.0% HealthWeak
  NASDAQ
Innate Pharma SA (IPHA)
Fair Value-3.8% Downside Fair Analyst239.0% Upside Market Cap166.4 M P/E-2.9x Yield0.0% HealthWeak
  NASDAQ
Instil Bio Inc (TIL)
Fair Value24.9% Upside Undervalued Analyst-3.6% Downside Market Cap49.169 M P/E-1.0x Yield0.0% HealthFair
  NASDAQ
Inventiva Sa (IVA)
Fair Value-22.6% Downside Overvalued Analyst215.3% Upside Market Cap1.058 B P/E-2.6x Yield0.0% HealthWeak
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Invivyd Inc (IVVD)
Fair Value13.4% Upside Fair Market Cap168.9 M P/E-2.3x Yield0.0% HealthFair
  NASDAQ
Jade Biosciences Inc (JBIO)
Fair Value-31.4% Downside Overvalued Analyst123.6% Upside Market Cap1.267 B P/E-13.5x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks Small-Cap Stocks
Janux Therapeutics Inc (JANX)
Fair Value26.3% Upside Undervalued Analyst132.4% Upside Market Cap973.3 M P/E-8.5x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Jasper Therapeutics Inc (JSPR)
Fair Value11.9% Upside Fair Market Cap18.632 M P/E-0.3x Yield0.0% HealthWeak
  NASDAQ
Kalaris Therapeutics Inc (KLRS)
Fair Value8.5% Upside Fair Analyst346.6% Upside Market Cap102.8 M P/E-2.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Keros Therapeutics Inc (KROS)
Fair Value37.3% Upside Undervalued Analyst103.5% Upside Market Cap203.2 M P/E-2.4x Yield0.0% HealthWeak
  NASDAQ
Kodiak Sciences Inc (KOD)
Fair Value-34.1% Downside Overvalued Analyst49.0% Upside Market Cap2.678 B P/E-11.8x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Korro Bio Inc (KRRO)
Fair Value21.7% Upside Undervalued Analyst73.9% Upside Market Cap163.7 M P/E-1.5x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Kymera Therapeutics Inc (KYMR)
Fair Value-32.2% Downside Overvalued Analyst22.0% Upside Market Cap8.587 B P/E-27.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Lantern Pharma Inc (LTRN)
Fair Value5.9% Upside Fair Analyst525.0% Upside Market Cap35.087 M P/E-2.2x Yield0.0% HealthFair
  NASDAQ
Legend Biotech Corp (LEGN)
Fair Value38.1% Upside Undervalued Analyst173.5% Upside Market Cap3.701 B P/E-14.7x Yield0.0% HealthGood
  NASDAQ
Liminatus Pharma Inc (LIMN)
Fair Value1.5% Upside Fair Market Cap5.305 M P/E-0.5x Yield0.0% HealthWeak
  NASDAQ
Longeveron LLC (LGVN)
Fair Value44.6% Upside Undervalued Analyst883.5% Upside Market Cap23.449 M P/E-1.0x Yield0.0% HealthFair
  NASDAQ
Lyell Immunopharma Inc (LYEL)
Fair Value0.5% Upside Fair Analyst183.6% Upside Market Cap333.3 M P/E-1.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
MeiraGTx Holdings PLC (MGTX)
Fair Value-7.9% Downside Fair Analyst133.4% Upside Market Cap1.138 B P/E-9.6x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Growth Small-Cap Stocks Small-Cap Stocks
Mirum Pharmaceuticals Inc (MIRM)
Fair Value-18.4% Downside Overvalued Analyst38.7% Upside Market Cap6.362 B P/E-8.1x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks
Moderna Inc (MRNA)
Fair Value-12.3% Downside Fair Analyst-9.6% Downside Market Cap22.752 B P/E-7.1x Yield0.0% HealthWeak
  NASDAQ Featured in High-Beta Stocks
Molecular Partners AG ADR (MOLN)
Fair Value-10.2% Downside Fair Analyst172.7% Upside Market Cap152.4 M P/E-2.1x Yield0.0% HealthFair
  NASDAQ
Monopar Therapeutics Inc (MNPR)
Fair Value-43.9% Downside Overvalued Analyst-2.0% Downside Market Cap793.5 M P/E-53.3x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks High-Momentum Stocks Small-Cap Stocks
Monte Rosa Therapeutics Inc (GLUE)
Fair Value-1.8% Downside Fair Analyst96.5% Upside Market Cap1.358 B P/E-10.1x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks High-Beta Momentum Small-Cap Stocks
MoonLake Immunotherapeutics (MLTX)
Fair Value17.8% Upside Fair Analyst59.5% Upside Market Cap1.481 B P/E-5.6x Yield0.0% HealthWeak
  NASDAQ Featured in Small-Cap Stocks
Nanobiotix (NBTX)
Fair Value-31.8% Downside Overvalued Analyst13.6% Upside Market Cap1.991 B P/E-71.9x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks Rapid Revenue Growth
NewAmsterdam Pharma Company NV (NAMS)
Fair Value-0.4% Downside Fair Analyst87.9% Upside Market Cap3.221 B P/E-15.1x Yield0.0% HealthFair
  NASDAQ
NewcelX AG (NCEL)
Fair Value7.3% Upside Fair Analyst546.1% Upside Market Cap18.574 M P/E-2.2x Yield0.0% HealthFair
  NASDAQ
NextCure Inc (NXTC)
Fair Value9.0% Upside Fair Analyst281.0% Upside Market Cap20.878 M P/E-0.3x Yield0.0% HealthFair
  NASDAQ
Nkarta Inc (NKTX)
Fair Value49.4% Upside Undervalued Analyst415.2% Upside Market Cap161.7 M P/E-1.6x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Nurix Therapeutics Inc (NRIX)
Fair Value-0.6% Downside Fair Analyst32.6% Upside Market Cap2.562 B P/E-7.6x Yield0.0% HealthWeak
  NASDAQ
Nuvalent Inc (NUVL)
Market Cap9.834 B P/E-21.9x
  NASDAQ
Olema Pharmaceuticals Inc (OLMA)
Fair Value-5.4% Downside Fair Analyst251.8% Upside Market Cap1.027 B P/E-5.5x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Onkure Therapeutics Inc (OKUR)
Fair Value21.7% Upside Undervalued Analyst368.8% Upside Market Cap165.6 M P/E-2.9x Yield0.0% HealthFair
  NASDAQ
Oric Pharmaceuticals Inc (ORIC)
Fair Value-18.5% Downside Overvalued Analyst61.2% Upside Market Cap1.396 B P/E-9.5x Yield0.0% HealthGood
  NASDAQ Featured in Overvalued Stocks Small-Cap Stocks
Pasithea Therapeutics Corp (KTTA)
Fair Value28.8% Upside Undervalued Analyst566.7% Upside Market Cap15.371 M P/E-0.8x Yield0.0% HealthFair
  NASDAQ
Passage Bio Inc (PASG)
Fair Value22.0% Upside Undervalued Analyst236.2% Upside Market Cap14.852 M P/E-0.4x Yield0.0% HealthFair
  NASDAQ
Pharming Group Nv (PHAR)
Fair Value14.6% Upside Fair Analyst221.6% Upside Market Cap758.6 M P/E81.6x Yield0.0% HealthGood
  NASDAQ Featured in High-Growth Small-Cap Stocks Small-Cap Stocks
Pmv Pharmaceuticals Inc (PMVP)
Fair Value30.1% Upside Undervalued Analyst241.9% Upside Market Cap62.398 M P/E-0.8x Yield0.0% HealthFair
  NASDAQ
Praxis Precision Medicines Inc (PRAX)
Fair Value-25.8% Downside Overvalued Analyst91.1% Upside Market Cap8.644 B P/E-27.3x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Precision BioSciences Inc (DTIL)
Fair Value-18.3% Downside Overvalued Analyst296.3% Upside Market Cap187.8 M P/E-4.3x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks
Prelude Therapeutics Inc (PRLD)
Fair Value1.3% Upside Fair Analyst76.2% Upside Market Cap448.3 M P/E-5.8x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Propanc Biopharma Inc (PPCB)
Fair Value-11.0% Downside Fair Market Cap2.324 M P/E-0.1x Yield0.0%
  NASDAQ
Quince Therapeutics Inc (QNCX)
Fair Value30.4% Upside Undervalued Analyst186.5% Upside Market Cap26.806 M P/E-0.8x Yield0.0% HealthFair
  NASDAQ
Rallybio Corp (RLYB)
Fair Value-11.1% Downside Fair Analyst-50.4% Downside Market Cap84.558 M P/E-10.9x Yield0.0% HealthFair
  NASDAQ Featured in High-Momentum Stocks
Recursion Pharmaceuticals Inc (RXRX)
Fair Value14.7% Upside Fair Analyst128.0% Upside Market Cap1.757 B P/E-3.0x Yield0.0% HealthFair
  NASDAQ Featured in High-Beta Stocks Small-Cap Stocks
Relay Therapeutics Inc (RLAY)
Fair Value-36.9% Downside Overvalued Analyst32.4% Upside Market Cap4.259 B P/E-15.7x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
RenovoRx Inc (RNXT)
Fair Value22.9% Upside Undervalued Analyst563.2% Upside Market Cap46.903 M P/E-3.9x Yield0.0% HealthGood
  NASDAQ
Replimune Group Inc (REPL)
Fair Value5.5% Upside Fair Analyst9.7% Upside Market Cap1.001 B P/E-3.2x Yield0.0% HealthFair
  NASDAQ Featured in Small-Cap Stocks
Revolution Medicines Inc (RVMD)
Fair Value-33.4% Downside Overvalued Analyst5.1% Upside Market Cap41.129 B P/E-30.5x Yield0.0% HealthFair
  NASDAQ Featured in Overvalued Stocks High-Beta Stocks
Explore listed stocks on NASDAQ with company information and fair value data.